In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.
Critics of FDA misunderstand Bayesian analysis, statisticians say.
Abigail Alliance says statisticians usurped control of oncology. Milken’s optimism fuels the movement.
Gottlieb questions ODAC’s independence.
Trending Stories
- With five-year cancer survival at an all-time high, does this mean people are living longer?
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - House passes three-year extension of ACA subsidies with bipartisan support
- When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care









